These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22456345)

  • 1. Identification of new biomarkers for Down's syndrome in maternal plasma.
    Heywood W; Mills K; Wang D; Hogg J; Madgett TE; Avent ND; Chitty LS
    J Proteomics; 2012 May; 75(9):2621-8. PubMed ID: 22456345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of a peptide SRM-based tandem mass spectrometry assay for prenatal screening of Down syndrome.
    Heywood W; Wang D; Madgett TE; Avent ND; Eaton S; Chitty LS; Mills K
    J Proteomics; 2012 Jun; 75(11):3248-57. PubMed ID: 22543281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary proteomic-based identification of a novel protein for Down's syndrome in maternal serum.
    Yu B; Zhang B; Wang J; Wang QW; Huang RP; Yang YQ; Shao SH
    Exp Biol Med (Maywood); 2012 May; 237(5):530-9. PubMed ID: 22678011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of maternal serum dimeric inhibin A as a first-trimester marker of Down's syndrome.
    Wallace EM; Grant VE; Swanston IA; Groome NP
    Prenat Diagn; 1995 Apr; 15(4):359-62. PubMed ID: 7617577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome.
    Wallace EM; Harkness LM; Burns S; Liston WA
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):483-6. PubMed ID: 7955459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
    Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K
    Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
    Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K
    Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].
    Yu DY; Fu P; Zhang ZH; Wang F; Han MY; Ren HY; Zhao W; Zhang K; Li S; Jiang N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):332-5. PubMed ID: 21644235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screen and identify of differential proteins expressed in the placenta of Down's syndrome].
    Yan LY; Sun CJ; Wang X; Chen Y; Zhang WY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):161-6. PubMed ID: 21575446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester or second-trimester screening, or both, for Down's syndrome.
    Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
    N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screening.
    Lambert-Messerlian GM; Palomaki GE; Eklund EE; Kloza EM; Neveux LM; Phipps MG; Canick JA
    J Med Screen; 2012 Dec; 19(4):164-70. PubMed ID: 23277614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Urinary Peptidome as a Noninvasive Biomarker Development Strategy for Prenatal Screening of Down's Syndrome.
    Shan D; Wang H; Khatri P; Niu Y; Song W; Zhao S; Jiang Y; Ma Q; Liu X; Zhang R; Wang W; Yin C
    OMICS; 2019 Sep; 23(9):439-447. PubMed ID: 31381471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome.
    Spencer K; Wood PJ; Anthony FW
    Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():219-20. PubMed ID: 8466163
    [No Abstract]   [Full Text] [Related]  

  • 20. Second trimester maternal serum ADAM12 levels in Down's syndrome pregnancies.
    Donalson K; Turner S; Wastell H; Cuckle H
    Prenat Diagn; 2008 Oct; 28(10):904-7. PubMed ID: 18785180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.